Stock listing

Poolbeg Pharma Plc

Selected listing: 7JN · FWB · EUR · DE

Poolbeg Pharma Plc (Frankfurt:7JN), Health Technology. Latest release Oct 6, 2026: POLB001 CRS Patent Granted in South Korea.

7JN:FWBEURDEUpdated October 2, 2026
Poolbeg Pharma Plc logo
Ticker
Frankfurt:7JN
Asset type
Stock
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
Frankfurt
Currency
EUR

Latest news from Poolbeg Pharma Plc

POLB001 CRS Patent Granted in South Korea

October 6, 2026

Interim Results for the six months to 30 June 2026

September 29, 2026

POLB 001 TOPICAL trial recruitment update

September 28, 2026

Interim data from POLB 001 TOPICAL clinical trial

September 24, 2026

Key Conference Participation in September 2026

September 3, 2026

All Poolbeg Pharma Plc news →

Events

Replays

  • POOLBEG PHARMA PLC (POLB) — Company Presentation

    Thu, Sep 24, 2026 · 09:00 AM ET

    Watch

  • Poolbeg Pharma PLC (POLB) Q4 2025 Earnings Call

    Tue, Apr 28, 2026 · 12:00 PM ET

    Watch

  • POOLBEG PHARMA PLC (POLB) — POLB 001 Phase 2a Trial Update

    Mon, Sep 29, 2025 · 12:00 PM ET

    Watch

Research Poolbeg Pharma Plc

Poolbeg Pharma Plc company profile

View the public company page for Poolbeg Pharma Plc on 6ix.

Poolbeg Pharma Plc news

Read company news and market updates connected to Poolbeg Pharma Plc.

Poolbeg Pharma Plc investor events

Find investor webinars, events, and replay context for Poolbeg Pharma Plc.

Alternate listings

POLB:LSE

GB · GBX

Alternate listing for Poolbeg Pharma Plc; the primary context on this page is 7JN:FWB.

POLBF:OTC

US · USD

Alternate listing for Poolbeg Pharma Plc; the primary context on this page is 7JN:FWB.

7JN:SWB

DE · EUR

Alternate listing for Poolbeg Pharma Plc; the primary context on this page is 7JN:FWB.